Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus

By sjmartinez • January 27, 2025

Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Böhmig GA, Boletis J, Briggs D, Claas FHJ, Couzi L, Cozzi E, Crespo M, De Vries APJ, Diekmann F, Durlik M, Glotz D, Helantera I, Jackson A, Jordan SC, Kuypers D, Lefaucheur C, Legendre C, Lorant T, Maggiore U, Mamode N, Marinaki S, Massart A, Müller T, Oberbauer R, Renders L, Roelen D, Taupin JL, Viklický O, Vittoraki A, de Weerd AE, Naesens M. Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus. Transpl Int. 2025 Jan 6;37:13886. doi: 10.3389/ti.2024.13886. PMID: 39867871; PMCID: PMC11758882.

Tags: desensitization, HLA incompatible, HLAi, imlifidase, kidney transplantation, Nephrology, Publications

Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning

Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, Chattopadhyay A, Sinha SK, Reddy ST, Singh R. Follistatin Mitigates Atherosclerosis Through Activation[...]

Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study

Htoo PT, Cho H, Paik JM, Bykov K, Everett BM, Glynn RJ, Shay C, Schmedt N, Wexler DJ, Patorno E. Cardiovascular outcomes of empagliflozin-GLP-1RA combination[...]

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]